Item Details

FDA's Drug and Device Review Process [electronic resource]: Hearing Before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, Second Session, February 6, 1992

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations
Format
Online; EBook; Government Document
Published
Washington : U.S. G.P.O., 1992.
Language
English
Series
ProQuest U.S. Congressional Hearings Digital Collection
SuDoc Number
Y 4.En 2/3:102-132
Description
iii, 178 p. : ill. ; 24 cm.
System requirements: PDF reader software.
Notes
  • Record is based on bibliographic data in ProQuest Congressional Hearings Digital Collection (last viewed Nov. 2009) Reuse except for individual research requires license from ProQuest, LLC.
  • Access to the Congressional Hearings Digital Collection is restricted by license to users on UVA's network. This document may also be available in print or microform at either UVa's Alderman or Law Libraries.
  • CIS No. HRG-1992-HEC-0005
  • Record is based on bibliographic data in ProQuest Congressional Hearings Digital Collection. Reuse except for individual research requires license from ProQuest, LLC.
Reproduction Notes
Electronic reproduction. [Bethesda, Md.] : ProQuest, 2004. digital, PDF file. ProQuest U.S. Congressional Hearings Digital Collection. Mode of access: World Wide Web via ProQuest website.
Logo for Copyright Not EvaluatedCopyright Not Evaluated
Technical Details

  • LEADER 02804nam a22003611a 4500
    001 cis2007459982
    006 m d f
    007 cr bn mmmapmmp
    008 091022s1992 dcua s f000 0 eng d
    043
      
      
    a| n-us---
    074
      
      
    a| 1019-A, 1019-B (MF)
    086
    0
      
    a| Y 4.En 2/3:102-132
    088
      
      
    a| Serial no. 102-132 (United States. Congress. House. Committee on Energy and Commerce)
    110
    1
      
    a| United States. b| Congress. b| House. b| Committee on Energy and Commerce. b| Subcommittee on Oversight and Investigations.
    245
    1
    0
    a| FDA's drug and device review process h| [electronic resource] : b| hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, second session, February 6, 1992.
    260
      
      
    a| Washington : b| U.S. G.P.O., c| 1992.
    300
      
      
    a| iii, 178 p. : b| ill. ; c| 24 cm.
    500
      
      
    a| Record is based on bibliographic data in ProQuest Congressional Hearings Digital Collection (last viewed Nov. 2009) Reuse except for individual research requires license from ProQuest, LLC.
    500
      
      
    a| Access to the Congressional Hearings Digital Collection is restricted by license to users on UVA's network. This document may also be available in print or microform at either UVa's Alderman or Law Libraries.
    500
      
      
    a| CIS No. HRG-1992-HEC-0005
    500
      
      
    a| Record is based on bibliographic data in ProQuest Congressional Hearings Digital Collection. Reuse except for individual research requires license from ProQuest, LLC.
    533
      
      
    a| Electronic reproduction. b| [Bethesda, Md.] : c| ProQuest, d| 2004. e| digital, PDF file. n| ProQuest U.S. Congressional Hearings Digital Collection. n| Mode of access: World Wide Web via ProQuest website.
    538
      
      
    a| System requirements: PDF reader software.
    610
    1
    0
    a| United States. b| Food and Drug Administration.
    650
      
    0
    a| Systemic scleroderma.
    650
      
    0
    a| Medical instruments and apparatus x| Safety regulations z| United States.
    650
      
    0
    a| Drugs x| Testing x| Law and legislation z| United States.
    776
    0
    8
    i| Print version: a| United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations t| FDA's drug and device review process w| (DGPO)93055342 w| (OCoLC)26700832
    776
    0
    8
    i| Microfiche version: a| United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations t| FDA's drug and device review process. d| [Bethesda, Md.] : ProQuest,[2004] o| CIS 92 H361-104 w| (ProQuest)cis09200728
    830
      
    0
    a| ProQuest U.S. Congressional Hearings Digital Collection.
    856
    4
    0
    u| http://proxy.its.virginia.edu/login?url=http://congressional.proquest.com/congcomp/getdoc?HEARING-ID=HRG-1992-HEC-0005 y| Electronic resource (PDF)
    998
      
      
    a| cis09200728
    040
      
      
    a| UMI c| UMI

Availability

Read Online